In the case of pancreatic cancer, the mutation of KRAS plays a critical role in cancer initiation and progression, which could be readily detectable at Stage 1 pancreatic intraepithelial neoplasia (PanIN) [32]. This evidence concerns the gene KRAS and pancreatic neoplasm.